Subtraction-Based Tumor Segmentation and Lesion-Centered pCR Prediction for the MAMA-MIA Challenge
Not on the map. Why?
Abstract (arXiv)
We describe the submission of team FME to the MAMA-MIA Challenge, which evaluated primary tumor segmentation and prediction of pathological complete response (pCR) from pretreatment dynamic contrast-enhanced breast MRI on an external multi-country cohort. For segmentation, we trained a five-fold residual-encoder nnU-Net ensemble using only the first post-contrast minus pre-contrast image, combined with mirroring test-time augmentation and largest-connected-component filtering. For pCR prediction, we ensembled 25 pretrained 3D video classifiers trained on lesion-centred crops from the pre-contrast and first two post-contrast volumes. FME ranked second in both tasks. The segmentation method achieved a combined performance-fairness score of 0.882, with Dice 0.713 and normalized Hausdorff distance 0.099. The pCR method achieved a combined score of 0.664, balanced accuracy of 0.541, and equalized-odds disparity of 0.212. The results indicate that subtraction-based input and ensembling support robust tumor segmentation under cross-site domain shift, whereas pCR prediction from baseline DCE-MRI alone remains limited. For the submission repository, see https://github.com/FraunhoferMEVIS/MAMA-MIA-Challenge-FME
Key facts. No citing papers in the map yet (data through 7 Oct 2026). Builds on 6 of its 16 references that are in the map. First posted on arXiv 29 Aug 2026.
Builds on
6 of 16 references.
References · 6
- 2016SGDR: Stochastic Gradient Descent with Warm Restartscited by 4,993
- 2017Mixed Precision Trainingcited by 1,135
- 2018Tune: A Research Platform for Distributed Model Selection and Trainingcited by 395
- 2024nnU-Net Revisited: A Call for Rigorous Validation in 3D Medical Image Segmentationcited by 235
- 2024A large-scale multicenter breast cancer DCE-MRI benchmark dataset with expert segmentationscited by 40
- 2026The MAMA-MIA Challenge: Advancing Generalizability and Fairness in Breast MRI Tumor Segmentation and Treatment Response Predictioncited by 2
Built on by
Not cited yet.